Peter H. Diamandis's most recent trade in Celularity Inc - Ordinary Shares - Class A was a trade of 84,746 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Dec. 19, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Celularity Inc - Ordinary ... | Peter H. Diamandis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2024 | 84,746 | 362,524 | - | - | Stock Option (Right to Buy) | |
| Celularity Inc - Ordinary ... | Peter H. Diamandis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2024 | 84,746 | 416,459 | - | - | Stock Option (Right to Buy) | |
| Celularity Inc - Ordinary ... | Peter H. Diamandis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2024 | 67,416 | 1,374,482 | - | 0 | Class A Common Stock | |
| Celularity Inc - Ordinary ... | Peter H. Diamandis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2024 | 67,416 | 201,723 | - | 0 | Class A Common Stock | |
| Vaxxinity Inc - Ordinary S... | Peter H. Diamandis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2023 | 132,352 | 132,352 | - | - | Stock option (right to buy) | |
| Vaxxinity Inc - Ordinary S... | Peter H. Diamandis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.57 per share. | 26 Apr 2023 | 429,037 | 859,641 | - | 0.6 | 244,551 | Class A common stock |
| Vaxxinity Inc - Ordinary S... | Peter H. Diamandis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Apr 2023 | 429,037 | 99,009 | - | - | Stock option (right to buy) | |
| Vaxxinity Inc - Ordinary S... | Peter H. Diamandis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.21 per share. | 26 Apr 2023 | 46,500 | 906,141 | - | 1.2 | 56,265 | Class A common stock |
| Vaxxinity Inc - Ordinary S... | Peter H. Diamandis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Apr 2023 | 46,500 | 732,642 | - | - | Stock option (right to buy) | |
| Celularity Inc - Ordinary ... | Peter H. Diamandis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.28 per share. | 10 Feb 2023 | 1,071,000 | 1,107,145 | - | 0.3 | 299,880 | Class A Common Stock |
| Celularity Inc - Ordinary ... | Peter H. Diamandis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2023 | 1,071,000 | 2,660,136 | - | - | Stock Option (Right to Buy) | |
| Vaxxinity Inc - Ordinary S... | Peter H. Diamandis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 129,187 | 129,187 | - | - | Stock option (right to buy) | |
| Vaxxinity Inc - Ordinary S... | Peter H. Diamandis | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.60 per share. | 24 Jan 2022 | 312,659 | 430,604 | - | 8.6 | 2,688,867 | Class A common stock |
| Vaxxinity Inc - Ordinary S... | Peter H. Diamandis | Director | Sale of securities on an exchange or to another person at price $ 13.00 per share. | 18 Nov 2021 | 248 | 90,499 | - | 13 | 3,224 | Class A common stock |
| Vaxxinity Inc - Ordinary S... | Peter H. Diamandis | Director | 15 Nov 2021 | 21,511 | 0 | - | - | Series A preferred stock | ||
| Vaxxinity Inc - Ordinary S... | Peter H. Diamandis | Director | 15 Nov 2021 | 13,824 | 13,824 | - | - | Class A common stock | ||
| Vaxxinity Inc - Ordinary S... | Peter H. Diamandis | Director | 15 Nov 2021 | 13,824 | 13,824 | - | - | Class A common stock |